Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash

Total article views   HTML views PDF downloads Totals
17,443 Dovepress* 16,151+ 1,510 17,661
PubMed Central* 1,292 327 1,619
Totals 17,443 1,837 19,280
*Since 4 September 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar